Please assess the completion status of the following clinical trial:

Trial Title: An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with moderate Rosacea (Global Severity Score of 3),~* Subjects willing to stop their current rosacea medication for at least 2 weeks~* Subjects must have an established routine of cosmetics application (e.g. must have been using the same facial foundation for at least 3 months and it is not expected to change during the study)~* Subjects must be willing to use their routine facial foundation and not change products while on study~Exclusion Criteria:~* Subjects who do not routinely wear facial foundation~* Subjects who failed to undergo a washout period of 14 days for the use of topical rosacea therapy, (for example: metronidazole, azelaic acid, sulfacetamide)~* Subjects who are unwilling to stop their current rosacea medications for 2 weeks

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: None): Female Subjects aged 20 to 75 inclusive, with a diagnosis of moderate (Global Severity Score of 3) Rosacea

Based on this trial design, predict the completion outcome and termination type (if applicable).